FDA approval of Voquezna (vonoprazan) tablets for the relief of heartburn associated with non-erosive GERD in adults – Phathom Pharmaceuticals
Phathom Pharmaceuticals, Inc. announced the FDA has approved Voquezna (vonoprazan) 10 mg tablets for the relief of heartburn associated with Non-Erosive Gastroesophageal Reflux Disease (Non-Erosive GERD) in adults…. read more.
